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Research
Hypertension or high blood pressure affects
approximately one-third of the U.S. adult
population (Fields et al. 2004) and is a lead-
ing risk factor for morbidity and mortality
from sudden death, heart disease, congestive
heart failure, stroke, and renal insufficiency.
For > 90% of hypertension, the cause is
unknown. It is suspected that multiple envi-
ronmental, psychosocial, and genetic factors
play a role in the disease and that these factors
may act additively or interactively (Schwartz
et al. 2003). 
Previous studies have shown an associa-
tion between biological markers of lead expo-
sure and elevated blood pressure. Many of the
studies that used blood lead levels (which
reﬂect mostly recent exposure) showed stable
effect estimates but inconsistent associations
with blood pressure (Hertz-Picciotto and
Croft 1993; Staessen et al. 1996); however,
more recent studies that used bone lead levels
[which reflect cumulative lead exposure and
are assessed using K-shell X-ray florescence
(KXRF) bone lead measurements] have shown
more consistent associations with increased
blood pressure and particularly with risk of
hypertension (Cheng et al. 2001; Glenn et al.
2003; Hu et al. 1996; Korrick et al. 1999; Lee
et al. 2001; Martin et al. 2006). Because
approximately 95% of the lead in adults is
stored in the bone, even with the signiﬁcant
decline in environmental lead exposure, the
release from this bone store to blood and soft
tissue can be an ongoing important source of
exposure and toxicity, especially in older popu-
lations (Rabinowitz 1991; Silbergeld 1991;
Silbergeld et al. 1993; Tsaih et al. 2001). 
Psychological stress can be defined as a
response to life events (stressors) that are per-
ceived or appraised as taxing the individual’s
ability to cope with the demands imposed. An
individual’s perception of a situation as stress-
ful is a pivotal component in the process
whereby a stressor affects health (Cohen et al.
1997; Lazarus and Folkman 1984; Monroe
and Kelley 1997). Previous studies have
shown psychosocial factors including stressful
tasks, psychological distress, occupational
stressors, and social alienation to be associated
with elevated blood pressure in both labora-
tory and cohort studies (e.g., Kaplan and
Nunes 2003; Levenstein et al. 2001). Some
cohort studies have also suggested that stress
or distress may play a role in the development
of hypertension (e.g., Davidson et al. 2000;
Jonas and Lando 2000; Jonas et al. 1997;
Levenstein et al. 2001; Markovitz et al. 1993;
Rutledge and Hogan 2002; Spiro et al. 1995). 
The mechanism by which self-reported
stress and lead jointly contribute to hyper-
tension is not well understood. Exposure to
low levels of lead seems to cause interference
with sodium transport, affect the renin–
angiotensin–aldosterone system, stimulate the
hypothalamic–pituitary axis, increase sympa-
thetic activity and catecholamines, and ele-
vate the level of reactive oxygen species (e.g.,
Gonick and Behari 2002; Schwartz 1991;
Vaziri and Sica 2004). Stress is also thought
to affect blood pressure via multiple mecha-
nisms activating the hypothalamic–pituitary
axis, the renin–angiotensin system, and the
sympathetic nervous system (e.g., Black and
Garbutt 2002), and through behavioral path-
ways as well. 
An interactive effect between psychologi-
cal stress and lead on blood pressure has been
demonstrated in animal studies, where lead
exposure was shown not only to produce a
stress reaction (Vyskocil et al. 1990, 1991a,
1991b) but also to heighten the harmful
impact of other types of stressful situations on
the function of the hypothalamic–
pituitary–adrenal axis (Virgolini et al. 2005)
as well as on neurotransmission and behavior
(Cory-Slechta et al. 2004). 
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BACKGROUND: Lead exposure and psychological stress have been independently associated with
hypertension in various populations, and animal studies suggest that when they co-occur, their
effects may be exacerbated. 
OBJECTIVES: We examined whether psychological stress modifies the impact of cumulative lead
exposure (measured as bone lead levels) on hypertension and blood pressure in Boston-area
community–exposed men participating in the Normative Aging Study. 
METHODS: We evaluated the modifying effect of stress on lead exposure on baseline hypertension
status (513 participants) and on blood pressure in those without hypertension (237 participants),
cross-sectionally. In baseline nonhypertensives, we examined the same risk factors in relation to
prospective risk of developing hypertension. 
RESULTS: Cross-sectional analysis revealed a positive interaction between stress and tibia lead on sys-
tolic blood pressure, after adjusting for age, body mass index, family history of high blood pressure,
education, smoking, alcohol consumption, physical activity, and nutritional factors. In prospective
multivariate analyses, high stress also modiﬁed the effect of tibia lead and patella lead on the risk of
developing hypertension. Those reporting high stress had 2.66 [95% confidence interval (CI),
1.43–4.95] times the risk of developing hypertension per standard deviation increase in tibia lead
and had 2.64 (95% CI, 1.42–4.92) times the risk per standard deviation increase in patella lead. 
CONCLUSION: To our knowledge, these are the ﬁrst analyses to look at interactive effects of stress
and lead on hypertension in humans. These results suggest that the effect of lead on hypertension is
most pronounced among highly stressed individuals, independent of demographic and behavioral
risk factors. 
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2007]We hypothesized that older men report-
ing high stress would have a steeper dose
response to the effect of bone lead on baseline
hypertension status and blood pressure and
on subsequent risk of developing hyperten-
sion compared with subjects reporting low
stress. To test these hypotheses, we evaluated
interactions between stress perception and
bone lead on baseline hypertension status,
systolic blood pressure (SBP), and diastolic
blood pressure (DBP) cross-sectionally, and
on incidence of hypertension prospectively, in
a sample of community-dwelling older men
from the Normative Aging Study (NAS).
Materials and Methods
This research was conducted on a subgroup of
the participants in the NAS, a longitudinal
study of aging established in 1963 by the
Veterans Administration (now the Department
of Veterans Affairs). The cohort and subgroup
of participants used in this research have been
described elsewhere (Cheng et al. 2001; Hu
et al. 1996). Briefly, the NAS is a closed
cohort of 2,280 male volunteers from the
Greater Boston area. Men were screened at
entry and enrolled if they had no history of
chronic medical conditions. In addition,
enrollment was restricted to those with SBP
< 140 mmHg and DBP < 90 mmHg. Since
enrollment, participants have been re-evalu-
ated every 3–5 years using questionnaires and
detailed onsite physical examinations. 
Between 1991 and 1996, 797 participants
had bone lead content measured by KXRF.
Participants were also given a series of ques-
tionnaires including questions about stress
perception between 1987 and 1993. KXRF
and questionnaire measurements were matched
for the same year; however, if no questionnaire
measurement was available for that year, the
questionnaire data in the evaluation cycle up to
3 years before were used. For this study, we
defined hypertension as diagnosis of hyper-
tension with treatment by the participant’s reg-
ular physician or SBP > 140 mmHg or DBP
> 90 mmHg during the study clinic examina-
tion. We used two sets of outcomes: a) hyper-
tensive status and blood pressure (in a subset
without hypertension) at the time of the ﬁrst
bone lead measurement (baseline exam), and
b) development of hypertension in subjects
without hypertension at baseline. For the lat-
ter, we used a follow-up period through
31 December 2004. 
This study complied with all applicable
requirements of the U.S. regulations, includ-
ing institutional review board approval and
written informed consent from all partici-
pants before administering study protocol.
This study was approved by the Human
Research Committees of Brigham and
Women’s Hospital and the Department of
Veterans Affairs Boston Medical Center.
Stress measure. To assess participant stress
perception, we administered the Health and
Social Behavior Questionnaire (Aldwin and
Revenson 1987; Aldwin et al. 1996; Yancura
et al. 2006). To anchor the stress response to a
concrete experience, participants were asked to
think of the most stressful thing that occurred
to them in the past month. The problem
could be major or minor, something that was
resolved or ongoing. Types of problems
reported related to health of self or others,
marital and wife, children and grandchildren,
social, work, retirement, ﬁnancial, general has-
sles, retirement, and bereavement (Aldwin
et al. 1996). They were then asked, compared
with other problems in the past, how stressful
this problem was (how much it bothered or
troubled them) rated on a 7-point scale where
1 = “not troubled” and 7 = “the most troubled
I’ve ever been.” This score provided our meas-
ure of self-reported stress, with higher num-
bers indicating a greater self-reported stress.
To facilitate the interpretability of interactive
effects, stress level was dichotomized based on
a median split, following other work in this
area (Ohman et al. 2007). Men with scores
below the median (≤ 5) were categorized as
low self-reported stress and those with scores
above (> 5) as high self-reported stress. 
Evidence of the validity of this measure
can be found in a recent study of stress and
coping, where this single item measure of
stress was found to be positively associated
with a sense of threat and negative affect, and
negatively associated with a sense of challenge
and positive affect (Yancura et al. 2006). To
further demonstrate the validity of the self-
reported stress measure for our study, it was
compared (in continuous form) with a global
distress index [General Severity Index (GSI)],
and two negative affect subscales (depression
and anxiety) derived from the Brief Symptom
Inventory, a self-report measure of psycho-
logical and somatic distress, and with the
Perceived Stress Scale (PSS; Cohen et al.
1983), available in a subset of the NAS sam-
ple. As expected, the scaled measure of self-
reported stress was moderately correlated with
GSI (r = 0.21; p < 0.01), the anxiety subscale
(r = 0.17; p < 0.01), depression subscale (r =
0.21; p < 0.01), and PSS (r = 0.23; p < 0.01). 
Bone lead measurement. We measured
bone lead for 30 min each at the mid-tibia
shaft and patella using a KXRF instrument
(ABIOMED, Inc., Danvers, MA). The tibia
and patella have been used for bone lead
research because they consist primarily of cor-
tical and trabecular bone, respectively, with
differing toxicity potential for each. Technical
speciﬁcations and validity of this instrument
are described in detail elsewhere (Burger et al.
1990; Hu et al. 1990, 1994).
Statistics. The main objectives of this
study were to evaluate whether stress affects
the relationship between bone lead and
a) baseline hypertension status, b) baseline SBP
and DBP in nonhypertensives (both cross-
sectional models) and c) the risk of developing
hypertension (prospective model among parti-
cipants not hypertensive at baseline).
Tibia and patella bone lead measurements
with estimated uncertainties > 10 and 15 μg/g
of bone, respectively, were excluded as part of
our laboratory’s quality control procedures
(Hu et al. 1996). In this study, six participants
were excluded. These levels of uncertainties
usually reflect excessive patient movement
during measurement. If a subject had more
than one bone lead or questionnaire measure-
ment, the earliest corresponding measure-
ments were used. Lead levels were modeled
per standard deviation change in tibia lead
(11.6 μg/g) and patella lead (17.1 μg/g). All
analyses use the dichotomized version of self-
reported stress unless otherwise stated.
Cross-sectional models. We used logistic
regression (dichotomous hypertension out-
come) and linear models (continuous blood
pressure outcomes) to evaluate the interactive
effect of perceived stress and bone lead at base-
line. Covariates were chosen based on biology,
other studies, and potential mediating effects
and included age and age squared (Cheng
et al. 2001); sodium, potassium, and calcium
intake (milligrams per day) (Appel 2003;
Cheng et al. 2001; Elmarsafawy et al. 2006);
family history of hypertension; body mass
index (BMI; kilograms per square meter); edu-
cational level (graduated high school vs. less
than high school); pack-years of smoking;
alcohol consumption (grams per day); and
physical activity (kilocalories per week). 
Prospective model. We used Cox propor-
tional hazards models to assess the interaction
of stress and bone lead on hypertension risk
prospectively. The same confounders were
included in the Cox proportional hazards
models as in the cross-sectional models. We
also tested the models to determine whether
they satisﬁed the assumption of proportional-
ity. The follow-up period was until a partici-
pant developed hypertension or 2004,
whichever came first. All analyses were con-
ducted using the Statistical Analysis System
(Unix SAS version 8.2; SAS Institute Inc.,
Cary, NC). A p-value < 0.05 was considered
signiﬁcant and < 0.10 marginally signiﬁcant.
Results
Sample characteristics. Of the initial group of
791 participants with valid bone lead measure-
ment, 513 also completed the stress measures.
Compared with those for whom stress was not
assessed, those with stress assessment did not
differ on age; BMI; family history of hyperten-
sion; alcohol consumption; pack-years of
smoking; physical activity; sodium, potassium,
calcium, and vitamin D intake; and DBP.
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SBP and lower anxiety and educational level.
The groups were comparable with respect to
tibia and patella lead levels. The mean (± SD)
age of the 513 participants was 66.9 ± 7.1
years. Mean blood pressure measures were, for
SBP, 135 ± 17.0 mmHg, and for DBP, 81 ±
9.6 mmHg. Mean tibia lead was 21.5 ± 13.4
μg/g, and mean patella lead 31.5 ± 19.3 μg/g. 
Of these 513 participants with both valid
bone lead measurements and stress assess-
ment, 276 had hypertension and 237 did not.
Table 1 shows the characteristics for hyper-
tensives and nonhypertensives. There was no
apparent difference between those with and
those without hypertension in likelihood of
participating in the stress and coping ques-
tionnaire. Among the subjects without hyper-
tension, compared with those who had no
stress assessment, those who had did not dif-
fer on any variable except DBP (higher in
those without stress measure).
Combined effects of stress and lead on
hypertension status and blood pressure: cross-
sectional analyses. Hypertension status.
When we controlled for confounders, neither
the main effects of self-reported stress and
bone lead (tibia lead or patella lead) nor the
interactive terms of self-reported stress by
bone lead were signiﬁcant predictors of base-
line hypertension status (Table 2). BMI, fam-
ily history of hypertension, and sodium intake
were signiﬁcant predictors.
Blood pressure in subjects without
hypertension. In the main effect models, con-
trolling for confounders, self-reported stress
was marginally significantly predictive [β =
2.59; 95% conﬁdence interval (CI), –0.47 to
5.64] of SBP. In the adjusted tibia lead inter-
action model, self-reported stress was a mar-
ginally significant predictor of SBP, with
those with high self-reported stress having an
estimated increase in SBP of 2.89 mmHg
(95% CI, –0.16 to 5.94) (Table 3). There
was also a signiﬁcant interaction between tibia
lead and stress (β = 3.77; 95% CI, 0.46 to
7.09). The slope of SBP for each standard
deviation increase of tibia lead for those with
high stress was 3.57 (95% CI, 0.39 to 6.75)
and for those with low stress –0.21 (95% CI,
–1.70 to 1.29) (Figure 1). Neither tibia lead,
self-reported stress, nor the interaction of
stress and tibia lead was predictive of DBP.
In the adjusted patella lead interaction
model, self-reported stress was a marginally
signiﬁcant predictor of SBP, with those with
high stress having an estimated increased SBP
of 2.98 mmHg (95% CI, –0.12 to 6.08)
(Table 3). There was no signiﬁcant interactive
effect of patella lead with self-reported stress,
although the direction of effects was similar to
those seen with tibia lead. Self-reported stress
was not predictive of DBP, and there was no
signiﬁcant interactive effect with patella lead. 
To take better advantage of the informa-
tion in the measure, we also examined the
above relationships using the continuous
form of the stress measure. Results were simi-
lar but of greater magnitude. In the main
effect model, self-reported stress was signifi-
cantly associated with systolic blood pressure
(β = 0.95; CI, 0.12 to 1.78), in addition to
being signiﬁcant in the models with tibia and
patella lead. The interaction with tibia lead
on systolic blood pressure was also signiﬁcant
(β = 1.03; 95% CI, 0.24 to 1.82). 
Prospective association of combined effects
of stress and lead on incident hypertension.
Among the 237 subjects without hyperten-
sion but with reported stress perception, there
were follow-up data for 220 men. The aver-
age years of follow-up was 6.2 ± 3.2 years,
ranging between 2.5 and 13.0 years. Of the
220, 97 new cases of hypertension were
observed during the follow-up period. In the
longitudinal models, all the variables were
found to be proportional. 
Table 4 shows the results of the interactive
models of bone lead and stress on incidence of
hypertension. When we controlled for the
same potential confounders as well as baseline
SBP and DBP, none of the main effects were
signiﬁcant; however, there was an interactive
effect for both the model with tibia lead and
the model with patella lead. For the tibia lead
model, those with high self-reported stress had
2.66 (95% CI, 1.43 to 4.95) times the risk of
developing hypertension for each standard
deviation increase of tibia lead than those with
low stress. For the patella lead model, those
with high self-reported stress had 2.64 (95%
CI, 1.42 to 4.92) times the risk of developing
hypertension for each standard deviation
increase of patella lead than those with low
stress. Similar to the cross-sectional models,
the interactions between bone lead and self-
reported stress were also observed when using
the continuous form of the stress measure [for
tibia, rate ratio (RR) = 1.30; 95% CI, 1.10 to
1.55; for patella, 1.23; 95% CI, 1.04 to 1.45].
Self-reported stress was also marginally signiﬁ-
cantly associated with development of hyper-
tension in the main effect model (RR = 1.13;
95% CI, 0.98 to 1.31) 
Discussion
We examined cross-sectional and prospective
effects of self-reported stress on the relation-
ship between bone lead and hypertension.
Our ﬁndings indicate that in this population
Peters et al.
1156 VOLUME 115 | NUMBER 8 | August 2007 • Environmental Health Perspectives
Table 1. Characteristics, lead exposure levels, and economic status of subjects with stress measures by
hypertension status at their ﬁrst bone lead measurement. 
Characteristic Hypertensives (n = 276) Nonhypertensives (n = 237)
Age (years)* 67.5 ± 6.8 66.2 ± 7.4
BMI (kg/m2)* 27.9 ± 3.7 26.8 ± 3.3
Family history of hypertension (%)a* 
Yes 45.8 27.4
No 54.2 72.6
Education (%)
Less than high school 41.1 43.1
Graduated high school 58.9 56.9
Self-reported stress (%)
High 21.4 21.5
Low 78.6 78.5
Sodium (mg/day)b 3,243 ± 939 3,404 ± 1,015
Potassium (mg/day)b 3,296 ± 640 3,315 ± 571
Calcium (mg/day)b* 804 ± 292 860 ± 310
Alcohol (g/day) 13.0 ± 16.2 14.0 ± 16.6
Smoking (pack-years) 19.2 ± 23.5 22.6 ± 23.9
Physical activity (kcal/week) 2,388 ± 1,708 2,638 ± 1,952
Trabecular lead (µg/g) 22.3 ± 14.6 20.5 ± 11.7
Patella lead (µg/g) 32.5 ± 20.1 30.3 ± 18.3
Blood lead (µg/dL) 6.3 ± 4.0 6.2 ± 4.2
SBP (mmHg)* 143.7 ± 16.7 124.0 ± 9.4
DBP (mmHg)* 84.8 ± 10.0 76.3 ± 6.5
Values are mean ± SD except where noted. 
aHistory of physician-diagnosed hypertension in subject’s father or mother. bAdjusted for total calorie intake. *p < 0.05 for
comparison between those with and without hypertension.
Table 2. Logistic regression of the effect of high
stress on the relationship of tibia lead and patella
lead on baseline hypertension status.
Covariate ORa (95% CI)
Model with tibia leadb
Hypertensives
High self-reported stress 1.05 (0.66 to 1.70)
Tibia lead 1.17 (0.88 to 1.42)
Tibia lead by high stress 1.00 (0.96 to 1.03)
Nonhypertensives Referent
Model with patella leadb
Hypertensives
High self-reported stress 1.07 (0.66 to 1.73)
Patella lead 1.08 (0.85 to 1.38)
Patella lead by high stress 1.02 (0.99 to 1.05)
Nonhypertensives Referent
aOdds ratios (ORs) based on 1-SD increase in tibia lead
(11.6 µg/g) or patella lead (17.1 µg/g). bModels adjusted for
age and age squared; BMI; family history of hypertension;
education; pack-years of smoking; alcohol intake; physical
activity; and sodium, calcium, and potassium intake.of older men, bone lead is more likely to be
associated with elevated SBP and with
increased risk of developing hypertension
among men with higher levels of self-reported
stress than among those reporting lower stress
levels. This lead–stress interaction is intrigu-
ing and consistent with ﬁndings in the animal
literature, but to our knowledge this is the
first time it has been reported in a human
population.
Previous research has found separate
relationships between stress and hypertension
and lead and hypertension, but our research is
among the first to suggest that they may
jointly have specific and detrimental effects
on cardiovascular health. Stress is suspected to
modify the relationship between other envi-
ronmental pollutants as well, and health out-
comes such as atopic disease and ulcer
(Shigemi et al. 1999; Wright 2005). For
example, Shigemi et al. (1999) observed an
interactive effect of perceived job stress on the
relationship between the history of peptic
ulcer and smoking. 
Findings of a link among self-reported
stress, lead, and SBP are particularly interest-
ing given that SBP is directly and continu-
ously related to the risk of stroke or coronary
event, and is often included in algorithms
developed for predicting the occurrence of
cardiovascular disease. An effect of lead and
stress was not seen on DBP, consistent with
other literature that found effects of stress and
of lead on only SBP (e.g., Cesana et al. 2003;
Cheng et al. 2001). One reason may be that
unlike SBP, which increases linearly with age,
DBP increases with age up to age 55 and then
declines thereafter (Burt et al. 1995; Izzo et al.
2000; Strandberg and Pitkala 2003). Because
of this relationship of DBP with age, elevated
DBP is more common in the young and mid-
dle-aged than in the elderly (Strandberg and
Pitkala 2003). Alternatively, elevated SBP has
become the most common form of hyperten-
sion in the U.S. aging population and is the
more important parameter for determining
risk of hypertension-related complications
(Izzo et al. 2000; Strandberg and Pitkala
2003). As a result, we might expect SBP to be
the more relevant parameter for our cohort,
which has an average age of 66.9 ± 7.1.
We found no interactive effect between
stress and bone lead in relation to whether a
participant was hypertensive at baseline.
Similar to other work, our definition of
hypertension included both those who had
doctor-diagnosed hypertension and those who
were grouped as hypertensive based on high
SBP or DBP during physical examination.
Diagnosed hypertension means that partici-
pants are being treated and as a result may be
changing behaviors and engaging in stress
management. In this case, they may appear to
have the same stress levels as those who are
not hypertensive, making it difﬁcult to see an
effect of stress on prevalent hypertension. 
For both patella and tibia lead, we
observed the trend of higher blood pressure in
the higher stress group; however, this rela-
tionship was significant only with tibia lead.
Tibia lead is made up mostly of cortical bone
and has slower turnover than patella bone,
which is made up mostly of trabecular bone
(Hu et al. 1991). The differences in effect in
cross-sectional analyses may reﬂect a differen-
tial effect of mobilizable versus long-term lead
stores; however, given the similarity in trends,
the differences are more likely the result of
the higher uncertainties in patella measure-
ment (Cheng et al. 2001; Hu et al. 1991).
This is additionally supported by the consis-
tency between findings from the cross-sec-
tional and prospective analyses. In the
prospective analyses, there was a significant
interaction with lead in both patella and tibia
with stress on the prospective incidence of
hypertension. 
Regulatory and legislative efforts to reduce
lead hazard in the United States beginning in
the 1970s have resulted in a continued
decline in blood lead in the adult population
(approximately an 87% decrease between
1976–1980 and 1999–2002) (Muntner et al.
2005; Pirkle et al. 1994). However, in adults,
most lead (approximately 95%) is stored in
bone, and this lead has a long half-life of years
to decades depending on the bone type. This
means that older populations, such as our
cohort, who have experienced decades of pre-
1970 environmental exposure can have sig-
nificant accumulation of lead in bone. The
constant low-level interchange with soft tissue
may then present a current source of toxicity,
which, when coupled with exposure to stress,
may put them at greater risk for hypertension.
Our results demonstrating an interactive
relationship may be confounded by a neuro-
logic effect of lead exposure on mood states
and also stress perception (with more negative
moods contributing to higher levels of per-
ceived stress). In a study of occupationally
exposed patients, integrated blood lead (which
was used in the study as a measure of cumula-
tive lead exposure) was related to general dis-
tress (Lindgren et al. 1999). Another study in
the NAS cohort found a cross-sectional associ-
ation between bone lead and phobic anxiety
(Rhodes et al. 2003). However, in our
prospective analysis, even among men with
the same cumulative lead exposure, those who
were experiencing higher stress were more
likely to develop higher blood pressures,
which would suggest that stress is modifying
the effect of lead. Of note, this prospective
analysis excluded hypertensives, and partici-
pants did not know their bone lead levels at
the time of stress assessment; so it is unlikely
that knowledge of blood pressure or bone lead
Stress modifies lead effect on hypertension
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Table 3. Multiple regression of the effect of high stress on the relationship of patella lead and tibia lead on
SBP and DBP.
SBP DBP
Covariate β 95% CI β 95% CI
Model with tibia leada
High self-reported stress 2.89*  –0.16 to 5.94 –0.58 –2.69 to 1.52
Tibia lead –0.27 –1.70 to 1.29 –0.30 –1.33 to 0.74
Tibia lead by high stress 3.77** 0.46 to 7.09 0.69 –1.60 to 2.98
Model with patella leada
High self-reported stress 2.98* –0.12 to 6.08 –0.74 –2.86 to 1.38
Patella lead 0.02 –1.44 to 1.48 –0.59 –1.59 to 0.41
Patella lead by high stress 2.60 –0.95 to 6.15 –0.23 –2.65 to 2.20
aParameter estimates are based on 1-SD increase in tibia lead (11.6 µg/g) or patella lead (17.1 µg/g).Models adjusted for
age and age squared; BMI; family history of hypertension; education; pack-years of smoking; alcohol intake; physical
activity; and sodium, calcium, and potassium intake. *p < 0.10. **p < 0.05.
Figure 1. The relationship between tibia lead and
estimated SBP for those with high self-reported
stress versus those with low self-reported stress. 
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Table 4. Cox proportional hazard regression of the
effect of high stress on the relationship of patella
lead and tibia lead on risk of hypertension.
Covariate RR (95% CI)
Model with tibia leada
High self-reported stress 1.30 (0.77 to 2.19)
Tibia lead 0.89 (0.65 to 1.23)
Tibia lead by high stress 2.66 (1.43 to 4.95)*
Model with patella leada
High self-reported stress 1.48 (0.89 to 2.45)
Patella lead 1.18 (0.92 to 1.51)
Patella lead by high stress 2.64 (1.42 to 4.92)*
aRate ratios are based on 1-SD in tibia lead (11.6 µg/g) or
patella lead (17.1 µg/g). Model adjusted for age and age
squared; BMI; family history of hypertension; education;
pack-years of smoking; alcohol intake; physical activity;
and sodium, calcium, and potassium intake, as well as
baseline systolic blood pressure and diastolic blood pres-
sure. *p < 0.05influenced stress perception. Notwith-
standing, this study does not address the issue
of the timing of exposures that contribute to
cumulative lead level, in terms of neurologic
development. Therefore, men who were
exposed earlier in life may have experienced
more lasting physiologic changes that may
have then made them more prone to judge
experiences as distressful (Aldwin et al. 1989;
Dohrenwend et al. 1984; Virgolini et al.
2005). Secondary analyses additionally con-
trolling for the Brief Symptom Inventory
global measure of psychological and somatic
distress yielded little change (< 1% reduction)
in the parameter estimates and no change
in the significance of the effects in any of
the models.
Significant relationships were observed
controlling for a number of potential con-
founders: age, BMI, family history of hyper-
tension, pack-years of smoking, alcohol
consumption, physical activity, and nutri-
tional factors; however, residual confounding
remains possible, and other important
variables may not have been considered.
Furthermore, this study may have limited gen-
eralizability, being a male cohort that was 97%
white with slightly higher than median
income. Because lead exposure and stress
appear to co-occur with low socioeconomic
status, these ﬁndings may have greater import
in these latter populations (Dohrenwend
1973; Virgolini et al. 2005). Previous analysis
of this cohort has shown that those who did
not participate in the bone lead substudy had
comparable blood pressures and blood lead
(Cheng et al. 2001). Moreover, both groups
had comparable self-reported stress and levels
of distress (i.e., anxiety). Thus, selection of
participants for this substudy is unlikely to
have been influenced by lead levels, stress
levels, or risk of hypertension. 
In conclusion, self-reported stress was
found to modify the effect of lead on blood
pressure and incident hypertension in a com-
munity sample of older men. Compared with
those with lower levels of self-reported stress,
among men with higher levels, there was a
signiﬁcantly stronger association between lead
levels and SBP. Additionally, in prospective
analysis, baseline self-reported stress modiﬁed
the effect of baseline bone lead on the inci-
dence of hypertension. With an increase in
the prevalence of hypertension, the aging of
generations with high community lead expo-
sure and the potentially deleterious effect of
hypertension on cardiovascular health, these
ﬁndings may point to intervention strategies
that can reduce the effects of lead on hyper-
tension. Additional studies are needed to con-
firm these findings in similar and more
diverse populations and to assess interactions
between environmental and psychosocial fac-
tors on other cardiovascular-related outcomes.
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